Sublingual asenapine: a guide to its use in acute mania in adults with bipolar I disorder


    loading  Checking for direct PDF access through Ovid

Abstract

Monotherapy or adjunctive therapy with sublingual asenapine improves acute mania in adults with bipolar I disorder. At week 3 of randomized, double-blind trials in adults with manic or mixed episodes associated with bipolar I disorder, monotherapy or adjunctive therapy with flexible-dose sublingual asenapine improved Young Mania Rating Scale total scores to a significantly greater extent than placebo. Sublingual asenapine is generally well tolerated and appears to have a generally favourable metabolic/endocrine profile.

    loading  Loading Related Articles